Skip to main content

Advertisement

SpringerLink
Log in

Oxidant/Antioxidant Disequilibrium in Idiopathic Pulmonary Fibrosis Pathogenesis

  • Review
  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Idiopathic pulmonary fibrosis is characterised by abnormal reepithelialisation and remodelling consequent to persistent stimuli or injury. The involvement of oxidative stress in alveolar injury, inflammation and fibrosis development has been suggested. Increased concentrations of lipid peroxidation products, oxidised proteins and an altered antioxidant enzyme status with the depletion of glutathione, the most abundant low-molecular-weight antioxidant, have often been reported in epithelial lining fluid of IPF patients. This review describes the sources of free radical generation, ROS-induced signalling pathways and mechanisms of oxidative stress damages in the pathogenesis of idiopathic pulmonary fibrosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Abbreviations

IPF:

Idiopathic pulmonary fibrosis

HRCT:

High-resolution computed tomography of the chest

ILD:

Interstitial lung diseases

References

  1. Cottin, V., F. Capron, P. Grenier, and J.F. Cordier. 2004. Diffuse idiopathic interstitial pneumonias, international multidisciplinary consensus classification by the American Thoracic Society and the European Respiratory Society, principal clinico-pathological entities, and diagnosis. Revue des Maladies Respiratoires 21 (2 Pt 1): 299–318.

    CAS  PubMed  Google Scholar 

  2. Raghu, G., H.R. Collard, J.J. Egan, F.J. Martinez, J. Behr, K.K. Brown, T.V. Colby, J.F. Cordier, K.R. Flaherty, J.A. Lasky, D.A. Lynch, J.H. Ryu, J.J. Swigris, A.U. Wells, J. Ancochea, D. Bouros, C. Carvalho, U. Costabel, M. Ebina, D.M. Hansell, T. Johkoh, D.S. Kim, King te Jr, Y. Kondoh, J. Myers, N.L. Müller, A.G. Nicholson, L. Richeldi, M. Selman, R.F. Dudden, B.S. Griss, S.L. Protzko, H.J. Schünemann, and ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. 2011. An official ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. American Journal of Respiratory and Critical Care Medicine 183: 788–824.

    PubMed  PubMed Central  Google Scholar 

  3. Nalysnyk, L., J. Cid-Ruzafa, P. Rotella, and D. Esser. 2012. Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature. European Respiratory Review 21: 355–361.

    PubMed  Google Scholar 

  4. Fois, A.G., P. Paliogiannis, S. Sotgia, A.A. Mangoni, E. Zinellu, P. Pirina, C. Carru, and A. Zinellu. 2018. Evaluation of oxidative stress biomarkers in idiopathic pulmonary fibrosis and therapeutic applications: a systematic review. Respiratory Research 19 (1): 51.

    PubMed  PubMed Central  Google Scholar 

  5. Johannson, K.A., J.R. Balmes, and H.R. Collard. 2015. Air pollution exposure: a novel environmental risk factor for interstitial lung disease? Chest 147 (4): 1161–1167.

    PubMed  PubMed Central  Google Scholar 

  6. Raghu, G., B. Rochwerg, Y. Zhang, C.A. Garcia, A. Azuma, J. Behr, J.L. Brozek, H.R. Collard, W. Cunningham, S. Homma, T. Johkoh, F.J. Martinez, J. Myers, S.L. Protzko, L. Richeldi, D. Rind, M. Selman, A. Theodore, A.U. Wells, H. Hoogsteden, H.J. Schünemann, and American Thoracic Society., European Respiratory society., Japanese Respiratory Society., Latin American Thoracic Association. 2015. An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine 192: e3–e19.

    PubMed  Google Scholar 

  7. Hilberg, O., U. Simonsen, R. du Bois, and E. Bendstrup. 2012. Pirfenidone: significant treatment effects in idiopathic pulmonary fibrosis. The Clinical Respiratory Journal 6 (3): 131–143.

    CAS  PubMed  Google Scholar 

  8. Wollin, L., I. Maillet, V. Quesniaux, A. Holweg, and B. Ryffel. 2014. Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis. The Journal of Pharmacology and Experimental Therapeutics 349 (2): 209–220.

    PubMed  Google Scholar 

  9. Magi, B., E. Bargagli, L. Bini, and P. Rottoli. 2006. Proteome analysis of bronchoalveolar lavage in lung diseases. Proteomics. 6: 6354–6369.

    CAS  PubMed  Google Scholar 

  10. Rottoli, P., B. Magi, M.G. Perari, S. Liberatori, N. Nikiforakis, E. Bargagli, R. Cianti, L. Bini, and V. Pallini. 2005. Cytokine profile and proteome analysis in BAL of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis. Proteomics. 5: 1423–1430.

    CAS  PubMed  Google Scholar 

  11. Ahmad, S., M.Y. Khan, Z. Rafi, H. Khan, Z. Siddiqui, S. Rehman, U. Shahab, M.S. Khan, M. Saeed, S. Alouffi, and M.S. Khan. 2018. Oxidation, glycation and glycoxidation - the vicious cycle and lung cancer. Seminars in Cancer Biology 49: 29–36.

    CAS  PubMed  Google Scholar 

  12. Gawda, A., G. Majka, B. Nowak, et al. 2017. Air pollution, oxidative stress, and exacerbation of autoimmune diseases. Central-European Journal of Immunology 42 (3): 305–312.

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Gonzalez-Gonzalez, F.J., N.S. Chandel, M. Jain, and G.R.S. Budinger. 2017. Reactive oxygen species as signaling molecules in the development of lung fibrosis. Translational Research 190: 61–68.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Ferrari, R.S., and C.F. Andrade. 2015. Oxidative stress and lung ischemia-reperfusion injury. Oxidative Medicine and Cellular Longevity 2015: 590987.

    PubMed  PubMed Central  Google Scholar 

  15. Chanda, D., E. Otoupalova, S.R. Smith, T. Volckaert, S.P. De Langhe, and V.J. Thannickal. 2019. Developmental pathways in the pathogenesis of lung fibrosis. Molecular Aspects of Medicine 65: 56–69.

    CAS  PubMed  Google Scholar 

  16. Landi, C., E. Bargagli, A. Carleo, L. Bianchi, A. Gagliardi, A. Prasse, M.G. Perari, R.M. Refini, L. Bini, and P. Rottoli. 2014. A system biology study of BALF from patients affected by idiopathic pulmonary fibrosis (IPF) and healthy controls. Proteomics. Clinical Applications 8 (11–12): 932–950.

    CAS  PubMed  Google Scholar 

  17. Liu, X., and Z. Chen. 2017. The pathophysiological role of mitochondrial oxidative stress in lung diseases. Journal of Translational Medicine 15 (1): 207.

    PubMed  PubMed Central  Google Scholar 

  18. Liguori, I., G. Russo, F. Curcio, G. Bulli, L. Aran, D. Della-Morte, G. Gargiulo, G. Testa, F. Cacciatore, D. Bonaduce, and P. Abete. 2018. Oxidative stress, aging, and diseases. Clinical Interventions in Aging 13: 757–772.

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Rottoli, P., B. Magi, R. Cianti, E. Bargagli, C. Vagaggini, N. Nikiforakis, V. Pallini, and L. Bini. 2005. Carbonylated proteins in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis. Proteomics 5 (10): 2612–2618.

    CAS  PubMed  Google Scholar 

  20. Bargagli, E., F. Penza, C. Vagaggini, B. Magi, M.G. Perari, and P. Rottoli. 2007. Analysis of carbonylated proteins in bronchoalveolar lavage of patients with diffuse lung diseases. Lung. 185 (3): 139–144.

    CAS  PubMed  Google Scholar 

  21. Malli, F., F. Bardaka, I. Tsilioni, E. Karetsi, K.I. Gourgoulianis, and Z. Daniil. 2013. 8-isoprostane levels in serum and bronchoalveolar lavage in idiopathic pulmonary fibrosis and sarcoidosis. Food and Chemical Toxicology 61: 160–163.

    CAS  PubMed  Google Scholar 

  22. Bargagli, E., F. Monaci, N. Bianchi, C. Bucci, and P. Rottoli. 2008. Analysis of trace elements in bronchoalveolar lavage of patients with diffuse lung diseases. Biological Trace Element Research 124 (3): 225–235.

    CAS  PubMed  Google Scholar 

  23. Bargagli, E., F. Lavorini, M. Pistolesi, E. Rosi, A. Prasse, E. Rota, and L. Voltolini. 2017. Trace metals in fluids lining the respiratory system of patients with idiopathic pulmonary fibrosis and diffuse lung diseases. Journal of Trace Elements in Medicine and Biology 42: 39–44.

    CAS  PubMed  Google Scholar 

  24. Sangiuolo, F., E. Puxeddu, G. Pezzuto, F. Cavalli, G. Longo, A. Comandini, D. di Pierro, M. Pallante, G. Sergiacomi, G. Simonetti, M. Zompatori, A. Orlandi, A. Magrini, M. Amicosante, F. Mariani, M. Losi, D. Fraboni, A. Bisetti, and C. Saltini. 2015. HFE gene variants and iron-induced oxygen radical generation in idiopathic pulmonary fibrosis. The European Respiratory Journal 45 (2): 483–490.

    CAS  PubMed  Google Scholar 

  25. Lee, J., I. Arisi, E. Puxeddu, L.K. Mramba, M. Amicosante, C.M. Swaisgood, M. Pallante, M.L. Brantly, C.M. Sköld, and C. Saltini. 2018. Bronchoalveolar lavage (BAL) cells in idiopathic pulmonary fibrosis express a complex pro-inflammatory, pro-repair, angiogenic activation pattern, likely associated with macrophage iron accumulation. PLoS One 13 (4): e0194803.

    PubMed  PubMed Central  Google Scholar 

  26. O'Dwyer, D.N., and B.B. Moore. 2019. Iron-ing out the roles of macrophages in idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine.

  27. Ye, Q., Y. Dalavanga, N. Poulakis, S.U. Sixt, J. Guzman, and U. Costabel. 2008. Decreased expression of haem oxygenase-1 by alveolar macrophages in idiopathic pulmonary fibrosis. The European Respiratory Journal 31 (5): 1030–1036.

    CAS  PubMed  Google Scholar 

  28. Iwata, Y., M. Okamoto, T. Hoshino, Y. Kitasato, Y. Sakazaki, M. Tajiri, K. Matsunaga, K. Azuma, T. Kawayama, T. Kinoshita, H. Imaoka, K. Fujimoto, S. Kato, H. Yano, and H. Aizawa. 2010. Elevated levels of thioredoxin 1 in the lungs and sera of idiopathic pulmonary fibrosis, non-specific interstitial pneumonia and cryptogenic organizing pneumonia. Internal Medicine 49 (22): 2393–2400.

    CAS  PubMed  Google Scholar 

  29. Gorowiec, M.R., L.A. Borthwick, S.M. Parker, J.A. Kirby, G.C. Saretzki, and A.J. Fisher. 2012. Free radical generation induces epithelial-to-mesenchymal transition in lung epithelium via a TGF-ß1-dependent mechanism. Free Radical Biology & Medicine 52 (6): 1024–1032.

    CAS  Google Scholar 

  30. Schamberger, A.C., H.B. Schiller, I.E. Fernandez, et al. 2016. Glutathione peroxidase 3 localizes to the epithelial lining fluid and the extracellular matrix in interstitial lung disease. Scientific Reports 6: 29952.

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Hecker, L., R. Vittal, T. Jones, R. Jagirdar, T.R. Luckhardt, J.C. Horowitz, S. Pennathur, F.J. Martinez, and V.J. Thannickal. 2009. NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nature Medicine 15: 1077–1081.

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Watson, W.H., J.D. Ritzenthaler, and J. Roman. 2016. Lung extracellular matrix and redox regulation. Redox Biology 8: 305–315.

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Hecker, L., N.J. Logsdon, D. Kurundkar, A. Kurundkar, K. Bernard, T. Hock, E. Meldrum, Y.Y. Sanders, and V.J. Thannickal. 2014. Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance. Science Translational Medicine 6: 231ra47.

    PubMed  PubMed Central  Google Scholar 

  34. Zhou, Y., X. Huang, L. Hecker, D. Kurundkar, A. Kurundkar, H. Liu, T.H. Jin, L. Desai, K. Bernard, and V.J. Thannickal. 2013. Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis. The Journal of Clinical Investigation 123 (3): 1096–1108.

    CAS  PubMed  PubMed Central  Google Scholar 

  35. Pardo, A., S. Cabrera, M. Maldonado, and M. Selman. 2016. Role of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosis. Respiratory Research 17: 23. https://doi.org/10.1186/s12931-016-0343-6 Review.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Estany, S., V. Vicens-Zygmunt, R. Llatjós, A. Montes, R. Penín, I. Escobar, A. Xaubet, S. Santos, F. Manresa, J. Dorca, and M. Molina-Molina. 2014. Lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGFβ1. BMC Pulmonary Medicine 14: 120.

    PubMed  PubMed Central  Google Scholar 

  37. Kliment, C.R., and T.D. Oury. 2010. Oxidative stress, extracellular matrix targets, and idiopathic pulmonary fibrosis. Free Radical Biology & Medicine 49 (5): 707–717.

    CAS  Google Scholar 

  38. Chen, X., C. Shi, H. Cao, L. Chen, J. Hou, Z. Xiang, K. Hu, and X. Han. 2018. The hedgehog and Wnt/ß-catenin system machinery mediate myofibroblast differentiation of LR-MSCs in pulmonary fibrogenesis. Cell Death & Disease 9 (6): 639.

    Google Scholar 

  39. Zeidler, P., A. Hubbs, L. Battelli, and V. Castranova. 2004. Role of inducible nitric oxide synthase-derived nitric oxide in silica-induced pulmonary inflammation and fibrosis. Journal of Toxicology and Environmental Health. Part A 67 (13): 1001–1026.

    CAS  PubMed  Google Scholar 

  40. Ricciardolo, F.L., P.J. Sterk, B. Gaston, and G. Folkerts. 2004. Nitric oxide in health and disease of the respiratory system. Physiological Reviews 84 (3): 731–765.

    CAS  PubMed  Google Scholar 

  41. Romanska, H.M., J.M. Polak, R.A. Coleman, R.S. James, D.W. Harmer, J.C. Allen, and A.E. Bishop. 2002. iNOS gene upregulation is associated with the early proliferative response of human lung fibroblasts to cytokine stimulation. The Journal of Pathology 197 (3): 372–379.

    CAS  PubMed  Google Scholar 

  42. Saleh, D., P.J. Barnes, and A. Giaid. 1997. Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine 155 (5): 1763–1769.

    CAS  PubMed  Google Scholar 

  43. Hsu, Y.-C., L.-F. Wang, and Y.W. Chien. 2007. Nitric oxide in the pathogenesis of diffuse pulmonary fibrosis. Free Radical Biology & Medicine 42 (5): 599–607.

    CAS  Google Scholar 

  44. Pullamsetti, S.S., R. Savai, R. Dumitrascu, B.K. Dahal, J. Wilhelm, M. Konigshoff, D. Zakrzewicz, and Ghofrani. 2011. The role of dimethylarginine dimethylaminohydrolase in idiopathic pulmonary fibrosis. Science Translational Medicine 3: 87ra53.

    PubMed  Google Scholar 

  45. Cameli, P., E. Bargagli, R.M. Refini, M.G. Pieroni, D. Bennett, and P. Rottoli. 2014. Exhaled nitric oxide in interstitial lung diseases. Respiratory Physiology & Neurobiology 197: 46–52.

    CAS  Google Scholar 

  46. Cameli, P., E. Bargagli, and P. Rottoli. 2016. Exhaled nitric oxide is not increased in pulmonary sarcoidosis. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases 33 (1): 39–40.

    PubMed  Google Scholar 

  47. Cameli, P., E. Bargagli, L. Bergantini, R.M. Refini, M. Pieroni, P. Sestini, and P. Rottoli. 2019. Evaluation of multiple-flows exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease. Journal of Breath Research.

  48. Walters, D.M., H.Y. Cho, and S.R. Kleeberger. 2008. Oxidative stress and antioxidants in the pathogenesis of pulmonary fibrosis: a potential role for Nrf2. Antioxidants & Redox Signaling 10 (2): 321–332.

    CAS  Google Scholar 

  49. Liu, Y., F. Lu, L. Kang, Z. Wang, and Y. Wang. 2017. Pirfenidone attenuates bleomycin-induced pulmonary fibrosis in mice by regulating Nrf2/Bach1 equilibrium. BMC Pulmonary Medicine 17 (1): 63.

    PubMed  PubMed Central  Google Scholar 

  50. Mazur, W., P. Lindholm, K. Vuorinen, et al. 2010. Cell-specific elevation of NRF2 and sulfiredoxin-1 as markers of oxidative stress in the lungs of idiopathic pulmonary fibrosis and non-specific interstitial pneumonia. APMIS 118 (9): 703–712.

    CAS  PubMed  Google Scholar 

  51. Carleo, A., E. Bargagli, C. Landi, D. Bennett, L. Bianchi, A. Gagliardi, C. Carnemolla, M.G. Perari, G. Cillis, A. Armini, L. Bini, and P. Rottoli. 2016. Comparative proteomic analysis of bronchoalveolar lavage of familial and sporadic cases of idiopathic pulmonary fibrosis. Journal of Breath Research 10 (2): 026007.

    CAS  PubMed  Google Scholar 

  52. Chilosi, M., A. Carloni, A. Rossi, and V. Poletti. 2013. Premature lung aging and cellular senescence in the pathogenesis of idiopathic pulmonary fibrosis and COPD/emphysema. Translational Research 162 (3): 156–173.

    CAS  PubMed  Google Scholar 

  53. Villegas, L., T. Stidham, and E. Nozik-Grayck. 2014. Oxidative stress and therapeutic development in lung diseases. Journal of Pulmonary & Respiratory Medicine 4 (4).

  54. Idiopathic Pulmonary Fibrosis Clinical Research Network, F.J. Martinez, J.A. de Andrade, K.J. Anstrom, T.E. King Jr., and G. Raghu. 2014. Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis. The New England Journal of Medicine 370 (22): 2093–2101. https://doi.org/10.1056/NEJMoa1401739.

    Article  CAS  Google Scholar 

  55. Oldham, J.M., S.F. Ma, F.J. Martinez, et al. 2015. TOLLIP, MUC5B, and the response to N-Acetylcysteine among individuals with idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine 192 (12): 1475–1482.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Surgery and Neurosciences, Respiratory Diseases and Lung Transplant Unit, University of Siena, Viale Bracci, 16, 53100, Siena, Italy

    Paolo Cameli, Laura Bergantini, Claudia Landi & Elena Bargagli

  2. Hannover Medical School, Hannover University, Hannover, Germany

    Alfonso Carleo & Antje Prasse

Authors
  1. Paolo Cameli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alfonso Carleo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Laura Bergantini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Claudia Landi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Antje Prasse
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Elena Bargagli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paolo Cameli.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The study was developed at Siena University.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cameli, P., Carleo, A., Bergantini, L. et al. Oxidant/Antioxidant Disequilibrium in Idiopathic Pulmonary Fibrosis Pathogenesis. Inflammation 43, 1–7 (2020). https://doi.org/10.1007/s10753-019-01059-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-019-01059-1

KEY WORDS

Search

Navigation